litlas
ログインアカウント作成

Dale Schenk

1986–2019 年に発表

60
論文数
28,629
被引用数
55
h 指数
60
i10 指数

被引用数

Dale Schenk の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 5 件1989 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 4 件1992 年: 被引用 33 件1993 年: 被引用 103 件1994 年: 被引用 137 件1995 年: 被引用 149 件1996 年: 被引用 201 件1997 年: 被引用 256 件1998 年: 被引用 250 件1999 年: 被引用 285 件2000 年: 被引用 450 件2001 年: 被引用 506 件2002 年: 被引用 524 件2003 年: 被引用 522 件2004 年: 被引用 517 件2005 年: 被引用 468 件2006 年: 被引用 538 件2007 年: 被引用 461 件2008 年: 被引用 511 件2009 年: 被引用 429 件2010 年: 被引用 571 件2011 年: 被引用 492 件2012 年: 被引用 534 件2013 年: 被引用 392 件2014 年: 被引用 426 件2015 年: 被引用 337 件2016 年: 被引用 307 件2017 年: 被引用 262 件2018 年: 被引用 230 件2019 年: 被引用 533 件2020 年: 被引用 509 件2021 年: 被引用 480 件2022 年: 被引用 397 件2023 年: 被引用 309 件2024 年: 被引用 393 件2025 年: 被引用 216 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,220 件、この内訳の 35.9%ドイツ: 引用元論文 856 件、この内訳の 7.3%イギリス: 引用元論文 789 件、この内訳の 6.7%中国: 引用元論文 542 件、この内訳の 4.6%日本: 引用元論文 516 件、この内訳の 4.4%スウェーデン: 引用元論文 422 件、この内訳の 3.6%カナダ: 引用元論文 417 件、この内訳の 3.6%イタリア: 引用元論文 375 件、この内訳の 3.2%オーストラリア: 引用元論文 337 件、この内訳の 2.9%スイス: 引用元論文 331 件、この内訳の 2.8%フランス: 引用元論文 322 件、この内訳の 2.7%ベルギー: 引用元論文 234 件、この内訳の 2%
0%35.9%その他 20.3%

機関

分野

  • Medicine78.6%
  • Biochemistry, Genetics and Molecular Biology10%
  • Neuroscience7.4%
  • Computer Science1.5%
  • Nursing0.4%
  • Immunology and Microbiology0.4%
  • その他1.7%

トピック

  • Alzheimer's disease research and treatments25.1%
  • Computational Drug Discovery Methods6.5%
  • Cholinesterase and Neurodegenerative Diseases6.3%
  • Parkinson's Disease Mechanisms and Treatments4.6%
  • Neuroinflammation and Neurodegeneration Mechanisms4.6%
  • Dementia and Cognitive Impairment Research3.6%
  • その他49.3%

共著者

全論文

検索で開く
  1. Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

    著者: John P. Anderson, Donald E. Walker, Jason Goldstein, Rian de Laat, Kelly Banducci, Russell Caccavello, Robin Barbour, Jiping Huang, Kristin Kling, Michael Lee, Linnea Diep, Pamela S. Keim, Xiaofeng Shen, Tim Chataway, Michael G. Schlossmacher, Peter Seubert, Dale Schenk, Sukanto Sinha, Wei Gai, Tamie J. Chilcote - Journal of Biological Chemistry 2006 被引用: 1,447

  2. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

    著者: Dale Schenk, Robin Barbour, Whitney Dunn, Grace Gordon, Henry Grajeda, Teresa Guido, Kang Hu, Jiping Huang, Kelly Johnson‐Wood, Karen Khan, Dora Kholodenko, Mike Lee, Zhenmei Liao, Ivan Lieberburg, Ruth Motter, Linda Mutter, Ferdie Soriano, George M. Shopp, Nicki Vasquez, Christopher Vandevert, Shannan Walker, Mark Wogulis, Ted Yednock, Dora Games, Peter Seubert - Nature 1999 被引用: 3,158

  3. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

    著者: Dora Games, David S. Adams, Ree Alessandrini, Robin Barbour, Patricia Borthelette, Catherine Blackwell, Tony Carr, James A. Clemens, Thomas Donaldson, Frances P. Gillespie, Terry Guido, S. Hagopian, Kelly Johnson‐Wood, Karen Khan, Mike Lee, Paul J. Leibowitz, Ivan Lieberburg, Sheila P. Little, Eliezer Masliah, Lisa McConlogue, Martin Montoya‐Zavala, Lennart Mucke, Lisa Paganini, Elizabeth Penniman, Mike Power, Dale Schenk, Peter Seubert, Ben Snyder, Ferdie Soriano, Hua Tan, James Vitale, Sam Wadsworth, Ben Wolozin, Jun Zhao - Nature 1995 被引用: 2,509

  4. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

    著者: Frédérique Bard, Catherine Cannon, Robin Barbour, Rae-Lyn Burke, Dora Games, Henry Grajeda, Teresa Guido, Kang Hu, Jiping Huang, Kelly Johnson‐Wood, Karen Khan, Dora Kholodenko, Mike Lee, Ivan Lieberburg, Ruth Motter, Minh Dang Nguyen, Ferdie Soriano, Nicki Vasquez, Kim Altman Weiss, Brent Welch, Peter Seubert, Dale Schenk, Ted Yednock - Nature Medicine 2000 被引用: 2,006

  5. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

    著者: Stephen Salloway, Reisa A. Sperling, S. Gilman, Nick C. Fox, Kaj Blennow, Murray A. Raskind, Marwan N. Sabbagh, Lawrence S. Honig, Rachelle S. Doody, Christopher H. van Dyck, Ruth A. Mulnard, Jerome Barakos, K. M. Gregg, E. Liu, Ivan Lieberburg, Dale Schenk, Ronald S. Black, Michael Grundman - Neurology 2009 被引用: 739

  6. Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models

    著者: Dora Games, Elvira Valera, Brian Spencer, Edward Rockenstein, Michael Mante, Anthony Adame, Christina Patrick, Kiren Ubhi, Silke Nuber, Patricia Sacayon, Wagner Zago, Peter Seubert, Robin Barbour, Dale Schenk, Eliezer Masliah - Journal of Neuroscience 2014 被引用: 320

  7. Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

    著者: Eliezer Masliah, Edward Rockenstein, Michael Mante, Leslie Crews, Brian Spencer, Anthony Adame, Christina Patrick, Margarita Trejo, Kiren Ubhi, Troy T. Rohn, Sarah Mueller-Steiner, Peter Seubert, Robin Barbour, Lisa McConlogue, Manuel Buttini, Dora Games, Dale Schenk - PLoS ONE 2011 被引用: 422

  8. The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

    著者: Christian Haass, Cynthia A. Lemere, Anja Capell, Martin Citron, Peter Seubert, Dale Schenk, Lars Lannfelt, Dennis J. Selkoe - Nature Medicine 1995 被引用: 581

  9. Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

    著者: Ruth Motter, Carmen Vigo‐Pelfrey, Dora Kholodenko, Robin Barbour, Kelly Johnson‐Wood, Douglas Galasko, L. Chang, Bruce L. Miller, Christopher M. Clark, R. Green, Darin E. Olson, Paula C. Southwick, R. Wolfert, B.S. Alelia E. Munroe, Ivan Lieberburg, Peter Seubert, Dale Schenk - Annals of Neurology 1995 被引用: 694

  10. Amyloid β-peptide is produced by cultured cells during normal metabolism

    著者: Christian Haass, Michael G. Schlossmacher, Albert Y. Hung, Carmen Vigo‐Pelfrey, Angela Mellon, Beth L. Ostaszewski, Ivan Lieberburg, Edward H. Koo, Dale Schenk, David B. Teplow, Dennis J. Selkoe - Nature 1992 被引用: 1,907

  11. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

    著者: Peter Seubert, Carmen Vigo‐Pelfrey, Fred Esch, Michael Lee, Harry F. Dovey, D. H. S. Davis, Sukanto Sinha, Michael Schiossmacher, Justine Whaley, Cathy Swindlehurst, Robert McCormack, Robert L. Wolfert, Dennis J. Selkoe, Ivan Lieberburg, Dale Schenk - Nature 1992 被引用: 1,740

  12. Purification and cloning of amyloid precursor protein β-secretase from human brain

    著者: Sukanto Sinha, John P. Anderson, Robin Barbour, Guriqbal S. Basi, Russell Caccavello, David L. Davis, Minhtam Doan, Harry F. Dovey, Normand L. Frigon, Jin Hong, Kirsten Jacobson-Croak, Nancy Jewett, Pamela S. Keim, Jeroen Knops, Ivan Lieberburg, Michael D. Power, Hua Tan, Gwen Tatsuno, Jay S. Tung, Dale Schenk, Peter Seubert, Susanna Suomensaari, Shuwen Wang, Donald E. Walker, Jun Zhao, Lisa McConlogue, Varghese John - Nature 1999 被引用: 1,598

  13. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice

    著者: Martin Citron, David Westaway, Weiming Xia, George A. Carlson, Thekla S. Diehl, Georges Lévesque, Kelly Johnson‐Wood, Michael Lee, Peter Seubert, Angela Davis, Dora Kholodenko, Ruth Motter, Robin Sherrington, Billie J. Perry, Hong Yao, Robert Strome, Ivan Lieberburg, Johanna M. Rommens, Soyeon Kim, Dale Schenk, Paul Fraser, Peter St George‐Hyslop, Dennis J. Selkoe - Nature Medicine 1997 被引用: 1,267

  14. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

    著者: Juha O. Rinne, David J. Brooks, Martin N. Rossor, Nick C. Fox, Roger Bullock, William E. Klunk, Chester A. Mathis, Kaj Blennow, Jerome Barakos, Aren Okello, Sofia Rodriguez Martinez de Liano, Enchi Liu, Martin Koller, Keith M. Gregg, Dale Schenk, Ronald S. Black, Michael Grundman - The Lancet Neurology 2010 被引用: 695

  15. Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson’s Disease

    著者: Gergely Tóth, Shyra J. Gardai, Wagner Zago, Carlos W. Bertoncini, Nunilo Cremades, Susan L. Roy, Mitali A. Tambe, Jean‐Christophe Rochet, Céline Galvagnion, Gaia Skibinski, Steven Finkbeiner, Michael P. Bova, Karin Regnström, San-San Chiou, Jennifer Johnston, Kari Callaway, John P. Anderson, Michael F. Jobling, Alexander K. Buell, Ted Yednock, Tuomas P. J. Knowles, Michele Vendruscolo, John Christodoulou, Christopher M. Dobson, Dale Schenk, Lisa McConlogue - PLoS ONE 2014 被引用: 152

  16. Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease

    著者: Kelly Johnson‐Wood, M. Lee, Ruth Motter, Kang Hu, Grace Gordon, Robin Barbour, Karen Khan, Marcia N. Gordon, Hua Tan, Dora Games, Ivan Lieberburg, Dale Schenk, Peter Seubert, Lisa McConlogue - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 被引用: 658

  17. The Role of Biomarkers in Clinical Trials for Alzheimer Disease

    著者: Leon J. Thal, Kejal Kantarci, Eric M. Reiman, William E. Klunk, Michael W. Weiner, Henrik Zetterberg, Douglas Galasko, Domenico Praticò, Sue Griffin, Dale Schenk, Eric Siemers - Alzheimer Disease & Associated Disorders 2006 被引用: 231

  18. Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model

    著者: John F. Reilly, Dora Games, Russell E. Rydel, Stephen B. Freedman, Dale Schenk, Warren G. Young, John H. Morrison, Floyd E. Bloom - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 175

  19. High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

    著者: Douglas Galasko, L. Chang, Ruth Motter, Christopher M. Clark, Jeffrey Kaye, David S. Knopman, Ronald G. Thomas, Dora Kholodenko, Dale Schenk, Ivan Lieberburg, Bruce L. Miller, R. Green, R. Basherad, L. Kertiles, Michael A. Boss, Peter Seubert - Archives of Neurology 1998 被引用: 446

  20. Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology

    著者: Frédérique Bard, Robin Barbour, Catherine Cannon, Robert Carretto, Michael Fox, Dora Games, Teresa Guido, Kathleen Hoenow, Kang Hu, Kelly Johnson‐Wood, Karen Khan, Dora Kholodenko, Celeste Lee, Mike Lee, Ruth Motter, Minh Dang Nguyen, Amanda Reed, Dale Schenk, Pearl Tang, Nicki Vasquez, Peter Seubert, Ted Yednock - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 407

  21. Aβ Species Removal After Aβ42Immunization

    著者: James A. R. Nicoll, Edward Barton, Delphine Boche, J. W. Neal, Isidró Ferrer, Petrina Thompson, Christina Vlachouli, David G. Wilkinson, Antony Bayer, Dora Games, Peter Seubert, Dale Schenk, Clive Holmes - Journal of Neuropathology & Experimental Neurology 2006 被引用: 266

  22. Morphological Characterization of Thioflavin-S-Positive Amyloid Plaques in Transgenic Alzheimer Mice and Effect of Passive Aβ Immunotherapy on Their Clearance

    著者: Thierry Bussière, Frédérique Bard, Robin Barbour, Henry Grajeda, Terry Guido, Karen Khan, Dale Schenk, Dora Games, Peter Seubert, Manuel Buttini - American Journal Of Pathology 2004 被引用: 173

  23. Immunotherapy Reduces Vascular Amyloid- in PDAPP Mice

    著者: Sally Schroeter, Karen Khan, Robin Barbour, Minh L. Doan, M. Chen, Terry Guido, Deborah R. Gill, G.S. Basi, Dale Schenk, Peter Seubert, Dora Games - Journal of Neuroscience 2008 被引用: 145

  24. Aβ Immunotherapy: Intracerebral Sequestration of Aβ by an Anti-Aβ Monoclonal Antibody 266 with High Affinity to Soluble Aβ

    著者: Kaoru Yamada, Chiori Yabuki, Peter Seubert, Dale Schenk, Yukiko Hori, Sumio Ohtsuki, Tetsuya Terasaki, Tadafumi Hashimoto, Takeshi Iwatsubo - Journal of Neuroscience 2009 被引用: 117